Using AI to improve pancreatic ultrasound scanning

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to develop and validate a deep-learning based artificial intelligence system to assist in pancreatic endoscopic ultrasound (EUS) scanning. The study will compare the accuracy of image recognition between the AI system and trained ultrasound endoscopists, as well as evaluate whether the AI can enhance the efficiency of the scanning process. Participants will undergo pancreatic EUS with or without the AI assistance, allowing for a direct comparison of outcomes. The trial will collect and analyze video and image data to assess the effectiveness of the AI system in identifying anatomical structures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Age ≥18 years old, \<80 years old 2.Patients who need endoscopic ultrasonography of pancreas; 3. Agree to participate in this study and sign the informed consent form.

Exclusion Criteria:

* Subjects who meet any of the following criteria cannot be selected for this trial:

First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:

1. Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
2. Anesthesia assessment failed
3. Pregnancy or breastfeeding
4. In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
5. Recent acute coronary syndrome or clinically unstable ischemic heart attack
6. Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure\> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.

Second. Disagree to participate in this study.

Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:

1. Pancreatic disease has undergone surgery or radiotherapy and chemotherapy beforehand;
2. Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.

Where it's running

• The Third Xiangya Hospital of Central South University
  Changsha, Hunan, China Recruiting

Study contacts

• Principal investigator: Xiaoyan Wang, Doctor — The Third Xiangya Hospital of Central South University
• Study coordinator: Xiaoyan Wang, Doctor
• Email: wxy20011@163.com
• Phone: +8613974889301

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis

  We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.

  Recruiting Phase 4 Medical University of Warsaw · Warsaw · NCT07024199

• Using AI to Diagnose Solid Pancreatic Lesions

  This study is testing a new AI system to see if it can help doctors better and faster diagnose solid pancreatic lesions during an ultrasound procedure.

  Recruiting at 2 sites Ruijin Hospital · Shanghai, Shanghai Municipality and 1 other locations · NCT06824909

• Evaluating pancreatic fistula rates after surgery using a specific stapler

  This study is testing if using a specific stapler during pancreas surgery can lower the chances of complications like pancreatic fistulas in patients.

  Recruiting University Hospital Heidelberg · Heidelberg, Baden-Wurttemberg · NCT06764134

• Creating a biobank for studying bilio-pancreatic diseases

  This study is creating a collection of biological samples and health information to see how genes and environment affect the risk of bilio-pancreatic diseases.

  Recruiting IRCCS San Raffaele · Milan · NCT06552078

• Comparing two methods for examining gastrointestinal lesions

  This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT06340620

• Investigating the impact of being a CF carrier on kidney and pancreatic health

  This study is trying to see if people who carry the cystic fibrosis gene are at a higher risk for kidney and pancreatic diseases compared to others.

  Recruiting University of Iowa · Iowa City, Iowa · NCT05474417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.